Other studies have found CEACAM6 to be of potential value for differential diagnosis of malignant vs benign tumors for breast cancer (with CEACAM6 protein levels measured in breast tissues42) and pancreatic cancer (with CEACAM6 protein levels measured in the bile43). The gene discussed is CEACAM6; the disease is familial pancreatic carcinoma.